Atlas Trials

Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Adult and Elderly Subjects

Clinical trial NCT02344134 · COMPLETED

Trial details

NCT number
NCT02344134
Sponsor
SK Chemicals Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Influenza, Human
Start date
2013-09-01
Primary completion
2013-11-01
Enrollment
1155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.